Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Maintenance phase, children and adolescents with depression
Maintenance treatment psychotic depression bipolar disorder schizophrenia
major depressive disorder (MDD) 335-361 bipolar depression comparison older people
Malabsorptive surgical procedures, bariatric surgery
Management of antipsychotic-induced hyperprolactinaemia.
Management of psychiatric disorders in people with 22q11.2 deletion syndrome.
Management of sexual adverse effects
Managing behavioural and psychological symptoms of dementia
Mania acute/hypomania benzodiazepines people living with human immunodeficiency virus treatment strategies antipsychotic treatments lithium treatment treatment in children and adolescents valproate treatment
Mania: other possible treatments
Mania (bipolar disorder) antipsychotics carbamazepine manic switch, depression in children and adolescents valproate treatment benzodiazepines lithium treatment treatment options
Maximum doses of antipsychotics according to European Medicines Agency labelling
Mechanism of action
Medical menopause using gonadotrophin-releasing hormone agonists
Medications other than benzodiazepines reported as treatments for catatonia/stupor (listed in αbetical order - no ranking or judgement is implied by the order)
Melatonin children and adolescents efficacy managing behavioural and psychological symptoms of dementia adverse effects, children and adolescents description for antipsychotic-induced weight gain
Melatonin use for sleep disturbance/insomnia Bipolar disorder in children and adolescents Autism spectrum disorder (ASD) in children and adolescents Melatonin in the treatment of insomnia in children and adolescents
Melperone
Memantine alzheimerâ™s disease Alternatives to clozapine Optimising clozapine treatment
Menopause depression/anxiety elderly care hormone replacement therapy Menopause psychosis diagnosis genitourinary symptoms and treatments increased adiposity effects psychological symptoms
Mental Health Act (MHA), England and Wales (1983) 629 Covert administration of medicines within food and drink The Mental Health Act in England and Wales Management of inappropriate sexual behaviour in older adults
Mephadone, misuse and dependence GHB and GBL dependence Drug-induced excited state Stimulant use disorder (SUD)
Metabolic abnormalities, antiretrovirals
Metformin for antipsychotic-induced weight gain possible mood improvement in type II diabetes
Methadone buprenorphine comparison general hospital settings initiation of treatment intoxication psychiatric hospital settings transferring back from buprenorphine withdrawal cautions hepatorenal dysfunction in overdose opioid substitution treatment titration schedules transition to buprenorphine
Methamphetamine use disorder detoxification psychotic symptoms
Methylphenidate
Mianserin, in overdose
Midazolam
mild cognitive impairment (MCI), treatments